Logo 1 Logo 2

Clinical Trial Details

Trial ID: L2770
Source ID: NCT00151762
Associated Drug: Colesevelam Hydrochloride
Title: Long-Term Study of Safety and Efficacy of WelChol® as an Additional Therapy in Patients With Type 2 Diabetes
Acronym:
Status: COMPLETED
Study Results: NO
Results:
Conditions: Type 2 Diabetes
Interventions: DRUG: Colesevelam hydrochloride
Outcome Measures: Primary: To evaluate safety and tolerability of colesevelam hydrochloride as add-on therapy | Secondary: To assess the long-term effect on hemoglobin A1c|To assess the long-term effect on fasting plasma glucose|To assess effects on lipids and lipoproteins
Sponsor/Collaborators: Sponsor: Daiichi Sankyo
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases: PHASE3
Enrollment: 780
Study Type: INTERVENTIONAL
Study Designs: Allocation: NON_RANDOMIZED|Intervention Model: |Masking: NONE|Primary Purpose: TREATMENT
Start Date: 2004-12
Completion Date: 2007-07
Results First Posted:
Last Update Posted: 2008-01-09
Locations: Birmingham, Alabama, United States|Tuscumbia, Alabama, United States|Jonesboro, Arkansas, United States|Little Rock, Arkansas, United States|Searcy, Arkansas, United States|Carmichael, California, United States|Concord, California, United States|Irvine, California, United States|La Jolla, California, United States|Los Angeles, California, United States|Los Gatos, California, United States|San Diego, California, United States|Spring Valley, California, United States|West Hills, California, United States|Washington, District of Columbia, United States|Cocoa Beach, Florida, United States|Coral Gables, Florida, United States|Largo, Florida, United States|Miami, Florida, United States|New Port Richey, Florida, United States|Pembroke Pines, Florida, United States|West Palm Beach, Florida, United States|Atlanta, Georgia, United States|Chicago, Illinois, United States|Evansville, Indiana, United States|Indianapolis, Indiana, United States|Lexington, Kentucky, United States|Louisville, Kentucky, United States|New Orleans, Louisiana, United States|Boston, Massachusetts, United States|Detroit, Michigan, United States|Troy, Michigan, United States|Edina, Minnesota, United States|Kansas City, Missouri, United States|St. Louis, Missouri, United States|Bozeman, Montana, United States|Butte, Montana, United States|Las Vegas, Nevada, United States|Rochester, New York, United States|Charlotte, North Carolina, United States|Hickory, North Carolina, United States|Statesville, North Carolina, United States|Winston Salem, North Carolina, United States|Cincinnati, Ohio, United States|Cleveland, Ohio, United States|Marion, Ohio, United States|Perrysburg, Ohio, United States|Oklahoma City, Oklahoma, United States|Tulsa, Oklahoma, United States|Portland, Oregon, United States|Beaver, Pennsylvania, United States|Charleston, South Carolina, United States|Columbia, South Carolina, United States|Bristol, Tennessee, United States|Morristown, Tennessee, United States|Corpus Christi, Texas, United States|Dallas, Texas, United States|Houston, Texas, United States|Midland, Texas, United States|San Antonio, Texas, United States|Richmond, Virginia, United States|Lakewood, Washington, United States|Mexico DF, Mexico|Lima, Peru
URL: https://clinicaltrials.gov/show/NCT00151762

Drug ID Drug Name Type DrugBank ID Targets Category Latest Progress